Physician profile
Anthony P Cucchi
NPI 1992839963
$696,509.97
in general payments reported to CMS, 2019-2025
13 companies · $117K in 2025
The $117K reported for 2025 was more than what 93% of Orthopaedic Surgery of The Spine providers received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $101K · 2020: $98K · 2021: $93K · 2022: $95K · 2023: $96K · 2024: $96K · 2025: $117K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $306K · Travel and Lodging: $2,974 · Food and Beverage: $765.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $305,861.11 |
| Travel and Lodging | $2,974.19 |
| Food and Beverage | $764.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $515,977.33 | 2019-2025 | Everest Spinal System |
| Globus Medical, INC. | $105,221.56 | 2019-2025 | Creo Addition, Creo |
| Vb Spine LLC | $68,139.52 | 2025 | Everest Spinal System |
| Cerapedics INC. | $2,714.70 | 2022 | |
| Alphatec Spine, INC | $2,479.04 | 2023 | Other - Miscellaneous, Safeop, Battalion Tlif - Pc |
| Life Spine, INC. | $741.80 | 2023 | Prolift, Trulift, Prolift Wedge |
| Boston Scientific Corporation | $533.72 | 2019-2025 | Intracept |
| Smith+Nephew, INC. | $259.63 | 2019-2020 | |
| Depuy Synthes Sales INC. | $244.80 | 2019-2020 | |
| Si-Bone, INC. | $124.00 | 2020-2022 | |
| Baxter Healthcare | $35.34 | 2021 | |
| Orthofix Medical, INC. | $19.88 | 2021 | |
| Spinal Elements, INC. | $18.65 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Cucchi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.